Crossmark

Orthologous CRISPR–Cas9 enzymes for combinatorial genetic screens

Crossref DOI link: https://doi.org/10.1038/nbt.4048

Published Online: 2017-12-18

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Najm, Fadi J

Strand, Christine http://orcid.org/0000-0001-5783-6667
Donovan, Katherine F

Hegde, Mudra

Sanson, Kendall R

Vaimberg, Emma W

Sullender, Meagan E http://orcid.org/0000-0001-6666-8650
Hartenian, Ella

Kalani, Zohra

Fusi, Nicolo http://orcid.org/0000-0002-4102-0169
Listgarten, Jennifer http://orcid.org/0000-0002-6600-1431
Younger, Scott T

Bernstein, Bradley E

Root, David E

Doench, John G http://orcid.org/0000-0002-3707-9889
License Information

Text and Data Mining valid from 2017-12-18
More Information

Article History

Received: 13 March 2017

Accepted: 4 November 2017

First Online: 18 December 2017

Competing interests

: J.L. and N.F. are employed by Microsoft Research. J.G.D. consults for Tango Therapeutics.